Eagles say a blood clot sidelines Jalen Hurts as Baun trade talk gains traction
The Eagles said a blood clot is sidelining Jalen Hurts, while trade talk involving Baun gained traction, raising parallel questions about the team’s quarterback availability and roster plans.
AI-assisted synthesis · Based on 4 outlets' reporting · Full text read from 2 of 4 outletsHow it's made
What happened
Key facts
- The Philadelphia Eagles said a blood clot was sidelining quarterback Jalen Hurts.
- Trade talk involving Eagles player Baun gained traction, according to the event headline.
- The Eagles drafted Jalen Hurts in the second round of the April 2020 NFL Draft.
- Hurts established himself as the Eagles’ starting quarterback over the 2021–2022 seasons.
- Philadelphia won the NFC East title in 2023.
The brief
The Philadelphia Eagles said an ultrasound revealed movement in a small blood clot in quarterback Jalen Hurts' calf, and CBS Sports reported that he would miss Week 6 against the Carolina Panthers, with a possible absence beyond that game.
The announcement puts the Eagles' starting quarterback's availability in question while CBS Sports also reported that the team's pursuit of Zack Baun was gaining traction. The Eagles' account, quoted by AtoZ Sports, traces the medical checks to a calf complaint Hurts raised after practice. The team said a follow-up ultrasound on Wednesday night showed movement in the clot.
It also said Hurts had played without limitation against the Jacksonville Jaguars in London and had practiced in full on Wednesday before that scan. Those details describe the team's account of his condition and activity; neither excerpt provides an independent medical assessment.
CBS Sports characterized the clot as superficial and said Hurts would be unavailable for the Carolina game in Week 6, possibly for longer. Us Weekly's headline likewise reported the Eagles' announcement of a blood clot and quoted the club's statement that Hurts' health and safety were its highest priority.
The sources do not give a return date or explain what medical criteria would determine when he can play again. The reports place the health news alongside speculation about the Eagles' roster options. Yahoo's headline said a trade for Zack Baun looked more realistic after the Hurts news, while CBS Sports reported that the Eagles' pursuit of Baun was gaining traction.
Neither source excerpt specifies proposed trade terms, identifies a counterpart, or reports that a deal has been completed. The available claims therefore concern the status of a possible pursuit, not a confirmed transaction. The immediate football consequence identified by CBS Sports is Hurts' expected absence against Carolina.
The report also says he could miss additional time, but gives no length for that possibility. The Eagles' account that he played without limitation and practiced in full before the later scan offers context for the timing of the news; it does not establish how long the clot will affect his availability.
For the Eagles, the reported decisions now center on managing Hurts' health and arranging the team for the Carolina game, while the Baun pursuit remains a separate roster-development story reported in connection with the quarterback news. No source gives a confirmed trade decision, a medical timeline, or further details about the club's next steps.
The verified account is limited to the Eagles' report of the clot and its movement, CBS Sports' description of Hurts' expected absence, and the reported interest in Baun.
Why it matters
- Hurts' expected absence against the Carolina Panthers leaves the Eagles without their starting quarterback for the Week 6 game, according to CBS Sports.
- The Eagles said a follow-up ultrasound showed movement in the clot, making his availability beyond that game an immediate team concern; CBS Sports said the absence could continue.
- The reported Baun pursuit is a possible roster move, but Yahoo and CBS Sports describe traction or increased realism rather than a completed trade.
What to watch next
- Whether the Eagles provide an update on Hurts' availability beyond the Week 6 game against the Carolina Panthers.
- Whether the Eagles' reported pursuit of Zack Baun results in a trade; no completed deal is reported.
- Whether the Eagles announce further information about the clot or Hurts' return to play.
How it's being covered
Coverage analysisShow details4 source articles · 4 unique outletsCoverage mix: Center Only· 3 CenterWhere the outlets are based: US/Canada 100%
- Coverage is currently concentrated among Center-rated outlets (3 of 3 rated sources); comparatively few Left or Right-rated outlets have published on the event.
- Coverage is currently concentrated among outlets based in US/Canada (4 of 4 geographically-identified sources).
How outlets' accounts compare
1 framing difference · 1 uncorroborated claim · 2 information gaps- CBS Sports directly connects its report of Hurts' expected Week 6 absence and possible longer absence with the Eagles' pursuit of Zack Baun; Yahoo's headline frames the Baun trade as looking more realistic after the Hurts news.
- The Eagles said Hurts' health and safety were their highest priority.
- The sources do not state the medical criteria for Hurts' return to play.
- The sources do not establish how long Hurts will be unavailable or whether the Eagles will complete a Baun trade.
How we got here
Immediate backdrop: Jalen Hurts joined the Philadelphia Eagles as a second‑round pick in the April 2020 NFL Draft and established himself as the club’s starting quarterback over the 2021–2022 seasons.
Structural roots: the NFL has maintained a midseason trade deadline framework since the league merger in 1970, with team roster rules and trading windows governed annually by the league operations manual and collective bargaining rules between the NFL and the NFL Players Association.
Original sources
4 articles from 4 outlets · US/Canada · Show allEvery story links to the reporting it was built from. How we choose sources
Spotted a factual error, a broken link or a misleading summary? Tell us.